Combination Therapy For Type 2 Diabetes
- 1 July 1999
- journal article
- Published by Elsevier in Endocrine Practice
- Vol. 5 (4) , 208-219
- https://doi.org/10.4158/ep.5.4.208
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes.Diabetes Care, 1998
- Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.Diabetes, 1998
- Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes MellitusAnnals of Internal Medicine, 1998
- Acarbose: Its Role in the Treatment of Diabetes MellitusAnnals of Pharmacotherapy, 1996
- MetforminNew England Journal of Medicine, 1996
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled studyDiabetes Care, 1994
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Sulfonylureas in NIDDMDiabetes Care, 1992
- Double-Blind Evaluation of Efficacy and Tolerability of Metformin in NIDDMDiabetes Care, 1991